TABLE 2.
Daily probabilities of incidence and clearance of molecular-BV (CST-IV) by community class in the HMP-UMB study in Birmingham, AL (N=100).
| LC/LG* | LI* | DA/DB/DC* | ||||
|---|---|---|---|---|---|---|
| Number of transitions to molecular-BV (incidence) | 65 | 85 | 142 | |||
| Number of non-transitions to molecular-BV (non-incidence) | 1175 | 722 | 317 | |||
| Number of transitions from molecular-BV (clearance) | 65 | 90 | 140 | |||
| Number of non-transitions to molecular-BV (non-clearance) | 93 | 122 | 1662 | |||
| Daily probability of incident molecular-BV | 0.032–0.050 | 0.067–0.103 | 0.222–0.296 | |||
| Daily probability of clearing molecular-BV | 0.281–0.426 | 0.301–0.424 | 0.058–0.080 | |||
| Number of consecutive days in molecular-BV | 1.8–2.9 | 1.7–2.7 | 10.2–14.4 | |||
| Number of consecutive days out of molecular-BV | 14.9–25.3 | 7.3–11.8 | 2.7–3.8 | |||
Participants were grouped into community class according to their main CST over the course of the study, determined through hierarchical clustering on CSTs. LC: mostly CST I; LG: mostly CST II; LI: mostly CST III; DA: mostly CST IV-A; DB: mostly CST IV-B, DC: mostly CST IV-C.